ELVAF
Price
$0.90
Change
-$0.05 (-5.26%)
Updated
Nov 8 closing price
Capitalization
9.39M
NRSN
Price
$1.52
Change
+$0.06 (+4.11%)
Updated
May 23 closing price
Capitalization
36.46M
4 days until earnings call
Interact to see
Advertisement

ELVAF vs NRSN

Header iconELVAF vs NRSN Comparison
Open Charts ELVAF vs NRSNBanner chart's image
Evolva Holding AG
Price$0.90
Change-$0.05 (-5.26%)
Volume$194
Capitalization9.39M
NeuroSense Therapeutics
Price$1.52
Change+$0.06 (+4.11%)
Volume$304.02K
Capitalization36.46M
ELVAF vs NRSN Comparison Chart
Loading...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVAF vs. NRSN commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVAF is a Hold and NRSN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (ELVAF: $0.90 vs. NRSN: $1.46)
Brand notoriety: ELVAF and NRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVAF: 100% vs. NRSN: 133%
Market capitalization -- ELVAF: $9.39M vs. NRSN: $36.46M
ELVAF [@Biotechnology] is valued at $9.39M. NRSN’s [@Biotechnology] market capitalization is $36.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $298.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVAF’s FA Score shows that 1 FA rating(s) are green whileNRSN’s FA Score has 0 green FA rating(s).

  • ELVAF’s FA Score: 1 green, 4 red.
  • NRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, ELVAF is a better buy in the long-term than NRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRSN’s TA Score shows that 6 TA indicator(s) are bullish.

  • NRSN’s TA Score: 6 bullish, 5 bearish.

Price Growth

ELVAF (@Biotechnology) experienced а 0.00% price change this week, while NRSN (@Biotechnology) price change was +15.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.05%. For the same industry, the average monthly price growth was +3.15%, and the average quarterly price growth was -3.91%.

Reported Earning Dates

NRSN is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRSN($36.5M) has a higher market cap than ELVAF($9.39M). NRSN YTD gains are higher at: 26.667 vs. ELVAF (0.000). ELVAF has higher annual earnings (EBITDA): 1.05M vs. NRSN (-10.41M). ELVAF has more cash in the bank: 6.75M vs. NRSN (344K). ELVAF (0) and NRSN (0) have equivalent revenues.
ELVAFNRSNELVAF / NRSN
Capitalization9.39M36.5M26%
EBITDA1.05M-10.41M-10%
Gain YTD0.00026.667-
P/E RatioN/AN/A-
Revenue00-
Total Cash6.75M344K1,963%
Total DebtN/A19K-
FUNDAMENTALS RATINGS
ELVAF: Fundamental Ratings
ELVAF
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
50
PRICE GROWTH RATING
1..100
73
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRSN
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RINYX47.280.13
+0.28%
Russell Inv International Devd Mkts Y
REEBX58.530.11
+0.19%
American Funds Europacific Growth R2E
FTQGX34.86N/A
N/A
Fidelity Focused Stock
SBRVX13.64N/A
N/A
Segall Bryant & Hamill Sm Cp Val Ret
RCGHX14.92-0.06
-0.40%
Virtus KAR Health Sciences C

ELVAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVAF has been loosely correlated with REPL. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVAF jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVAF
1D Price
Change %
ELVAF100%
N/A
REPL - ELVAF
60%
Loosely correlated
-4.68%
CLYYF - ELVAF
47%
Loosely correlated
N/A
IBIO - ELVAF
39%
Loosely correlated
+6.18%
GLABF - ELVAF
34%
Loosely correlated
N/A
NRSN - ELVAF
24%
Poorly correlated
+4.11%
More

NRSN and

Correlation & Price change

A.I.dvisor tells us that NRSN and SLRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NRSN and SLRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRSN
1D Price
Change %
NRSN100%
+4.11%
SLRX - NRSN
32%
Poorly correlated
-0.91%
CTMX - NRSN
31%
Poorly correlated
+4.69%
DNLI - NRSN
29%
Poorly correlated
-1.76%
VKTX - NRSN
27%
Poorly correlated
-2.70%
KANT - NRSN
27%
Poorly correlated
+8.00%
More